Aoife Mac Dermott
Image of Aoife MacDermott

Aoife Mac Dermott

Senior Associate

Email

aoife.macdermott@aoshearman.com

Phone

+44 20 3088 1566

Offices

London

V-CARD
Aoife has significant experience advising a variety of clients on a wide range of M&A transactions and corporate matters, with a particular focus on transactions in the Life Sciences & Healthcare and Consumer & Retail sectors.
She has deep experience of private M&A, in particular navigating complex brand and product acquisitions and disposals, as well as capital raises, joint ventures, public takeovers, reorganisations and restructurings.

Expertise

Industries

Experience

Representative matters

  • Exponent Private Equity on its investment in Chanelle Pharma, Ireland’s largest manufacturer of generic pharmaceuticals by way of auction.
  • A global life sciences company on the multi-jurisdictional carve-out of its established products business. 
  • Asahi Group on its USD 11.3bn acquisition of Carlton & United Breweries, the Australian arm of Anheuser-Busch InBev by way of auction.
  • Life Healthcare on its GBP 910m sale of Alliance Medical Group to iCON Infrastructure.
  • Kyowa Kirin International on its joint venture collaboration with Grünenthal in respect of KKI's established medicines portfolio.
  • SIG on its EUR 222.7m sale of its Air Handling Division to France Air Group.
  • SIG on its agreement with Clayton Dublilier & Rice to invest up to GBP 85m in SIG and SIG’s related firm placing, placing and open offer raising an additional GBP 80m. 
  • WPP on the USD 3.1bn sale of a 60% stake in Kantar to Bain Capital.

Qualifications

Admissions

Admitted as a Solicitor (Ireland), 2016

Admitted as a Solicitor (England and Wales), 2019

Academic

Bachelor of Civil Law (with Politics) (Intl.), University College Dublin, 2012
Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.